MORGAN STANLEY

Position in GNLX — GENELUX Corp

CIK 895421 NEW YORK, NY

Position in GNLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$213,074

-$188,869 QoQ

Shares Held

88,048

-4.5% QoQ

Ownership

0.196%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 15% Shared 0% None 85%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. GNLX ranks #326 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$213,074	88,048	-4.5%	Shares	Defined	2026-05-15
2025-12-31	$401,943	92,189	+52.0%	Shares	Defined	2026-05-27
2025-09-30	$254,703	60,644	+7.3%	Shares	Defined	2026-05-27
2025-06-30	$162,181	56,510	-18.1%	Shares	Defined	2025-08-15
2025-03-31	$186,326	69,010	+28.2%	Shares	Defined	2025-05-15
2024-12-31	$127,062	53,840	+79.9%	Shares	Defined	2025-05-15
2024-09-30	$70,919	29,924	-66.4%	Shares	Defined	2025-05-14
2024-06-30	$173,918	89,191	+50.3%	Shares	Defined	2025-05-14
2024-03-31	$381,540	59,338	-4.2%	Shares	Defined	2024-10-17
2023-12-31	$867,342	61,909	+107.0%	Shares	Defined	2024-08-16
2023-09-30	$732,322	29,903	+695.5%	Shares	Defined	2023-11-15
2023-06-30	$122,992	3,759	+89.5%	Shares	Defined	2023-08-14
2023-03-31	$55,036	1,984	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.